0001493152-26-019340.txt : 20260428
0001493152-26-019340.hdr.sgml : 20260428
20260428161530
ACCESSION NUMBER: 0001493152-26-019340
CONFORMED SUBMISSION TYPE: SCHEDULE 13G
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20260428
DATE AS OF CHANGE: 20260428
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: ABEONA THERAPEUTICS INC.
CENTRAL INDEX KEY: 0000318306
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
EIN: 830221517
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SCHEDULE 13G
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-33655
FILM NUMBER: 26908012
BUSINESS ADDRESS:
STREET 1: 6555 CARNEGIE AVE, 4TH FLOOR
CITY: CLEVELAND
STATE: OH
ZIP: 44103
BUSINESS PHONE: 646-813-4701
MAIL ADDRESS:
STREET 1: 6555 CARNEGIE AVE, 4TH FLOOR
CITY: CLEVELAND
STATE: OH
ZIP: 44103
FORMER COMPANY:
FORMER CONFORMED NAME: PLASMATECH BIOPHARMACEUTICALS INC
DATE OF NAME CHANGE: 20140922
FORMER COMPANY:
FORMER CONFORMED NAME: ACCESS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19960209
FORMER COMPANY:
FORMER CONFORMED NAME: CHEMEX PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19920703
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: HIRSCHMAN ORIN
CENTRAL INDEX KEY: 0001131362
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: SCHEDULE 13G
MAIL ADDRESS:
STREET 1: 101 EAST 52ND ST
CITY: NEW YORK
STATE: NY
ZIP: 10022
SCHEDULE 13G
1
primary_doc.xml
X0202
SCHEDULE 13G
0001131362
XXXXXXXX
LIVE
Common Stock, $0.01 par value
03/31/2026
0000318306
ABEONA THERAPEUTICS INC.
00289Y206
6555 Carnegie Avenue
4th Floor
Cleveland
OH
44103
Rule 13d-1(b)
Orin Hirschman
b
X1
3100000.00
0.00
3100000.00
0.00
3100000.00
N
5.4
HC
IN
AIGH Capital Management LLC
b
DE
3100000.00
0.00
3100000.00
0.00
3100000.00
N
5.4
IA
OO
ABEONA THERAPEUTICS INC.
6555 Carnegie Avenue, 4th Floor, Cleveland, OH, 44103
This Schedule 13G is being jointly filed by each of the following persons pursuant to Rule 13d-1 promulgated by the Securities and Exchange Commission pursuant to Section 13 of the Securities Exchange Act of 1934, as amended (the "Act"):
(i) AIGH Capital Management, LLC, a Maryland limited liability company ("AIGH CM"), as an Advisor or Sub-Advisor with respect to shares of Common Stock (as defined in Item 2(d) below) held by AIGH Investment Partners, L.P., and WVP Emerging Manger Onshore Fund, LLC - AIGH Series.
(ii) AIGH Investment Partners, L.L.C., a Delaware limited liability company ("AIGH LLC";), with respect to shares of Common Stock (as defined in Item 2(d) below) directly held by it;
(iii) Mr. Orin Hirschman ("Mr. Hirschman"), who is the Managing Member of AIGH Capital Management, LLC and president of AIGH LLC, with respect to shares of Common Stock (as defined in Item 2(d) below) indirectly held through AIGH CM, directly by AIGH LLC and Mr. Hirschman and his family directly.
AIGH Capital Management LLC., AIGH Investment Partners LLC, and Mr. Hirschman are hereinafter sometimes collectively referred to as the "Reporting Persons." Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party.
The principal office and business address of AIGH Capital Management LLC, AIGH Investment Partners LLC, and Mr.Hirschman is: 6006 Berkeley Avenue, Baltimore MD 21209
See Item 2(a) above and Item 4 of each cover page.
N
IA
3,100,000
5.4
3,100,000
0
3,100,000
0
Y
Y
Y
Y
Y
N
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
Orin Hirschman
/s/ Orin Hirschman
Orin Hirschman
04/28/2026
AIGH Capital Management LLC
/s/ Orin Hirschman
Orin Hirschman, Managing Member
04/28/2026